Tumor regression mediated by Mycobacterium bovis (strain BCG). Effects of isonicotinic acid hydrazide, cortisone acetate, and antithymocyte serum.
D000818:Animals; D000907:Antibodies, Bacterial; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D006968:Hypersensitivity, Delayed / Q000175:diagnosis; D007538:Isoniazid / Q000627:therapeutic use*; D008297:Male; D008748:Methylcholanthrene; D051379:Mice; D008809:Mice, Inbred C3H; D009163:Mycobacterium bovis / Q000276:immunology*; D009368:Neoplasm Transplantation; D012075:Remission, Spontaneous; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous; D014374:Tuberculin Test
D000907:Antibodies, Bacterial; D000961:Antilymphocyte Serum; D008748:Methylcholanthrene; D003348:Cortisone; D007538:Isoniazid